CVI Investments, Inc recently disclosed that they own a 6.8% stake in AmpliPhi Biosciences (NASDAQ:APHB) in a Schedule 13G disclosure that was filed with the Securities and Exchange Commission (SEC) on Friday, November 25th. The investor owns 1,133,334 shares of the stock worth about $646,000. The reporting parties listed on the disclosure included CVI Investments, Inc and Heights Capital Management, Inc. The filing is available through EDGAR at this hyperlink.
Shares of AmpliPhi Biosciences (NASDAQ:APHB) remained flat at $0.57 during mid-day trading on Friday. The firm has a 50 day moving average of $0.18 and a 200 day moving average of $0.20. The stock’s market cap is $6.34 million. AmpliPhi Biosciences has a 52-week low of $0.07 and a 52-week high of $0.34.
AmpliPhi Biosciences Company Profile
AmpliPhi Biosciences Corporation is a biotechnology company. The Company is focused on the discovery, development and commercialization of phage therapeutics. The Company is engaged in identifying, characterizing and developing naturally occurring bacteriophages with its collaboration partners in bacteriophage biology, synthetic biology and manufacturing, to develop second-generation bacteriophage products.